The Boston Children’s team targeted the enzyme arginase 2 (ARG2), which tumors use to clear the excess nitrogen that’s produced when they break down protein. “They need ARG2 to get rid of the extra nitrogen and prevent ammonia from accumulating,” explained Nada Kalaany, an associate professor in pediatrics at Harvard Medical School, who led the research, in a statement. Read more . . .